Bristol Myers Squibb vs YouShift

Side-by-side comparison of AI visibility scores, market position, and capabilities

Bristol Myers Squibb leads in AI visibility (75 vs 35)

Bristol Myers Squibb

LeaderHealthcare Tech

Enterprise

Princeton NJ biopharma (NYSE: BMY) at $48.3B 2024 revenue; Eliquis $13.3B, Opdivo $9.2B, Cobenfy schizophrenia launch; $23B acquisitions (Karuna+Mirati+RayzeBio) building next pipeline vs. Pfizer and Merck.

AI VisibilityBeta
Overall Score
B75
Category Rank
#112 of 290
AI Consensus
59%
Trend
stable
Per Platform
ChatGPT
67
Perplexity
77
Gemini
84

About

Bristol Myers Squibb (BMS) is a Princeton, New Jersey-based global biopharmaceutical company — publicly traded on the New York Stock Exchange (NYSE: BMY) as an S&P 500 Healthcare component — discovering, developing, and delivering innovative medicines for serious diseases including cancer, cardiovascular disease, immunology, and neuroscience through approximately 34,000 employees worldwide. In fiscal year 2024, BMS reported total revenue of $48.3 billion (+7% year-over-year), with its Growth Portfolio generating $22.6 billion (+17%), driven by blockbusters Eliquis ($13.3B anticoagulant), Opdivo ($9.2B immuno-oncology), and Revlimid ($5.8B multiple myeloma). New product revenue surged 77% to $3.6 billion, led by schizophrenia treatment Cobenfy (formerly KarXT), CAR-T therapy Breyanzi, anemia drug Reblozyl, and Opdualag checkpoint inhibitor combination. CEO Dr. Christopher Boerner assumed leadership in November 2023, accelerating BMS's pipeline expansion through three transformative acquisitions in 2024: Karuna Therapeutics ($14B, Cobenfy/KarXT for schizophrenia and Alzheimer's agitation), Mirati Therapeutics ($4.8B, KRAS-targeted oncology), and RayzeBio ($4.1B, radiopharmaceutical cancer therapy).

Full profile

YouShift

EmergingHealthcare Tech

General

US AI healthcare scheduling agent for hospitals replacing complex manual shift management; Rippling-for-healthcare vision with optimization algorithms and agentic AI targeting nursing staff scheduling competing with Kronos and UKG Workforce.

AI VisibilityBeta
Overall Score
D35
Category Rank
#1159 of 1167
AI Consensus
83%
Trend
stable
Per Platform
ChatGPT
35
Perplexity
31
Gemini
36

About

YouShift is a United States-based AI healthcare workforce management platform — building the operating system for healthcare staffing starting with AI-powered scheduling agents that replace the complex, administrator-dependent scheduling software that hospitals currently use. Founded to address the operational inefficiency at the intersection of clinical workforce management and scheduling complexity, YouShift applies optimization algorithms and agentic AI to generate shift schedules that simultaneously respect hospital staffing requirements (coverage ratios, certification requirements, department-specific rules) and staff preferences (requested days off, preferred shift patterns, commute constraints) — eliminating the manual schedule-building work that currently requires full-time administrative staff at most hospital systems.

Full profile

AI Visibility Head-to-Head

75
Overall Score
35
#112
Category Rank
#1159
59
AI Consensus
83
stable
Trend
stable
67
ChatGPT
35
77
Perplexity
31
84
Gemini
36
81
Claude
33
72
Grok
38

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.